Aduro biotech

Join LinkedIn today for free. Aduro BioTech is a development-stage biopharmaceutical company engaged in the development of early-stage cancer therapies. NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the H. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on . Sector Drug Discovery and Development. Organization Description Aduro BioTech , Inc.

Aduro has developed or acquired novel technology platforms designed to activate potent and lasting immune responses against cancer: . ADRO) ownership summary provides a high level overview of up-to-date institutional holdings and insider trades. Biotech and Pharmaceutical. Monitor, Director of Quality, Senior Administrative Assistant and more! Explore the billions of dollars special interest groups are spending on lobbying in Washington, D. Salary, bonuses, stock options, stock awards and other compensation information for top executives at ADURO BIOTECH INC. The New York Times and other leading providers.

Aduro is advancing multiple therapeutic and prophylactic vaccines for cancer and infectious diseases based on its attenuated Listeria monocytogenes vaccine. ADRO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Morningstar real-time stock quotes, graphs, and independent analysis for ADRO keep you informed. Merck (known as MSD outside the United States and Canada) for the initiation of a Phase I clinical trial of its anti-CDantibody. Free step-by-step journey directions and updated timetables for Bus, BART, Train, Cable Car in Berkeley.

While described hereinafter in terms of expression of fusion proteins by Listeria monocytogenes, the present invention is applicable to expression of fusion proteins generally. Applicant: ADURO BIOTECH , INC. GSK will be eligible to receive undisclosed commercial milestones and royalties. With a particular focus on one or more of the following disciplines: immunology, oncology,. There interactions are authentic, commitment is high.

They work with intensity, enjoy collaboration, and thrive on the notion that they are making an impact by developing novel cancer therapies. Aduro is a fast-pace fast-growing company with a refreshing culture. Their Mission: Our employees come to work every day . Series B round to advance small molecules that modulate anti- tumor immunity pathways.

Financing StartUps and SMEs.